PAULO EDUARDO NARCIZO DE SOUZA

Dr. PAULO EDUARDO NARCIZO DE SOUZA

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
VMVictoria Monge-Fuentes
Victoria Monge-Fuentes
LMLuis Alexandre Muehlmann
Luis Alexandre Muehlmann
João Paulo Figueiró LongoJoão Paulo Figueiró Longo
João Paulo Figueiró Longo
JSJaqueline Rodrigues Silva
Jaqueline Rodrigues Silva
MFMaria Luiza Fascineli
Maria Luiza Fascineli
RARicardo Azevedo
Ricardo Azevedo

13 May 2015 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
Luis Alexandre MUEHLMANNLuis Alexandre MUEHLMANN
Luis Alexandre MUEHLMANN
MRMosar Correa Rodrigues
Mosar Correa Rodrigues
João Paulo Figueiró LongoJoão Paulo Figueiró Longo
João Paulo Figueiró Longo
MGMônica Pereira Garcia
Mônica Pereira Garcia
KPKaren Rapp Py-Daniel
Karen Rapp Py-Daniel
RARicardo Azevedo
Ricardo Azevedo
Photodynamic therapy (PDT) combines light, molecular oxygen and a photosensitizer to induce oxidative stress in target cells. Certain hydrophobic photosensitizers, such as aluminium-phthalocyanine chloride (AlPc), have significant potential for antitumor PDT applications. However, hydrophobic molecules often require drug-delivery systems, such as nanostructures, to improve their pharmacokinetic properties and to prevent aggregation, which has a quenching effect on the photoemission properties in aqueous media. As a result, this work aims to develop and test the efficacy of an AlPc in the form of a nanoemulsion to enable its use in anticancer PDT. The nanoemulsion was developed using castor oil and Cremophor ELP®, and a monodisperse population of nanodroplets with a hydrodynamic diameter of approximately 25 nm was obtained. While free AlPc failed to show significant activity against human breast adenocarcinoma MCF-7 cells in an in vitro PDT assay, the AlPc in the nanoemulsion showed intense photodynamic activity. Photoactivated AlPc exhibited a 50 % cytotoxicity concentration (CC50) of 6.0 nM when applied to MCF-7 cell monolayers and exerted a powerful cytotoxic effect on MCF-7 cell spheroids. Through the use of spontaneous emulsification, a stable AlPc nanoemulsion was developed that exhibits strong in vitro photodynamic activity on cancer cells.

30 January 2018 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
MSMayara Simonelly Costa dos Santos
Mayara Simonelly Costa dos Santos
ASAna Luísa Silva
Ana Luísa Silva
LMLudmilla Moura
Ludmilla Moura
LPLeonardo Giordano Paterno
Leonardo Giordano Paterno
PSPAULO EDUARDO NARCIZO DE SOUZA
PAULO EDUARDO NARCIZO DE SOUZA
SBSônia Báo
Sônia Báo
In the photodynamic therapy (PDT), the photosensitizer absorbs light and transfers the energy of the excited state to the oxygen in the cell environment producing reactive oxygen species (ROS), that in its turn, may cause cell damage. In the photothermal therapy (PTT), light also is responsible for activating the photothermal agent, which converts the absorbed energy in heat. Graphene oxide is a carbon-based material that presents photothermal activity. Its physical properties allow the association with the photosensitizer methylene blue and consequently the production of ROS when submitted to light irradiation. Therefore, the association between nanographene oxide and methylene blue could represent a strategy to enhance therapeutic actions. In this work, we report the nanographene oxide-methylene blue platform (NanoGO-MB) used to promote tumor ablation in combination with photodynamic and photothermal therapies against a syngeneic orthotopic murine breast cancer model. In vitro, NanoGO-MB presented 50% of the reactive oxygen species production compared to the free MB after LED light irradiation, and a temperature increase of ~ 40 °C followed by laser irradiation. On cells, the ROS production by the nanoplatform displayed higher values in tumor than normal cells. In vivo assays demonstrated a synergistic effect obtained by the combined PDT/PTT therapies using NanoGO-MB, which promoted complete tumor ablation in 5/5 animals. Up to 30 days after the last treatment, there was no tumor regrowth compared with only PDT or PTT groups, which displayed tumoral bioluminescence 63-fold higher than the combined treatment group. Histological studies confirmed that the combined therapies were able to prevent tumor regrowth and liver, lung and spleen metastasis. In addition, low systemic toxicity was observed in pathologic examinations of liver, spleen, lungs, and kidneys. The treatment with combined PDT/PTT therapies using NanoGO-MB induced more toxicity on breast carcinoma cells than on normal cells. In vivo, the combined therapies promoted complete tumor ablation and metastasis prevention while only PDT or PTT were unable to stop tumor development. The results show the potential of NanoGO-MB in combination with the phototherapies in the treatment of the breast cancer and metastasis prevention.

1 July 2018 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
PCPaolin Rocio Cáceres-Vélez
Paolin Rocio Cáceres-Vélez
MFMaria Luiza Fascineli
Maria Luiza Fascineli
Marcelo Henrique SousaMarcelo Henrique Sousa
Marcelo Henrique Sousa
CGCesar Koppe Grisolia
Cesar Koppe Grisolia
LYLuis Yate
Luis Yate
RARicardo Azevedo
Ricardo Azevedo

1 July 2012 in Physica B: Condensed Matter
Verified
Journal Article
Closed access
FAF.H. Aragón
F.H. Aragón
PSPAULO EDUARDO NARCIZO DE SOUZA
PAULO EDUARDO NARCIZO DE SOUZA
JCJosé A. H. Coaquira
José A. H. Coaquira
PHP. Hidalgo
P. Hidalgo
DGD. Gouvêa
D. Gouvêa

1 August 2017 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
LMLuciano Ferreira Morgado
Luciano Ferreira Morgado
ATAna Regina Franchi Trávolo
Ana Regina Franchi Trávolo
LMLuís Alexandre Muehlmann
Luís Alexandre Muehlmann
PSPAULO EDUARDO NARCIZO DE SOUZA
PAULO EDUARDO NARCIZO DE SOUZA
RNRodrigo Barbosa Nunes
Rodrigo Barbosa Nunes
João Paulo Figueiró LongoJoão Paulo Figueiró Longo
João Paulo Figueiró Longo